Cancer Types

Myelodysplastic Syndrome

Group of disorders caused by poorly formed blood cells. Risk-stratified by IPSS-R; treatment ranges from observation to azacitidine and stem cell transplant.

Myelofibrosis

Nasopharyngeal Cancer

Neuroblastoma

Most common extracranial solid tumor in children. High-risk disease treated with multimodal therapy plus anti-GD2 immunotherapy and emerging GD2 CAR-T.

Neuroendocrine Tumors

Tumors arising from neuroendocrine cells. Treatment includes somatostatin analogs, PRRT (Lu-177 DOTATATE), and targeted therapy.

Non-Hodgkin Lymphoma

Diverse group of B-cell, T-cell, and NK-cell lymphomas. CAR-T therapy has transformed treatment for relapsed/refractory aggressive B-cell lymphomas.

Non-Melanoma Skin Cancer

Non-Small Cell Lung Cancer

The most common type of lung cancer (~85% of cases). Includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma subtypes.

Ocular Cancer

Oral Cancer

Oropharyngeal Cancer

Osteosarcoma

Most common primary bone cancer, often affecting adolescents and young adults.

Ovarian Cancer

Cancer of the ovaries, most commonly epithelial ovarian cancer. PARP inhibitors are pivotal for BRCA-mutated and HRD-positive tumors.

Pancreatic Cancer

Aggressive cancer of the pancreas, typically pancreatic ductal adenocarcinoma (PDAC). Treatment includes surgery (Whipple), FOLFIRINOX or gemcitabine-based chemotherapy, and emerging targeted/immunotherapy approaches for select patients.

Pediatric Acute Lymphoblastic Leukemia

Most common childhood cancer. Cure rates exceed 85% with multi-agent chemotherapy; CAR-T for refractory cases.

Pediatric Acute Myeloid Leukemia

Pediatric Brain Tumor

Pediatric Ewing Sarcoma

Pediatric Osteosarcoma

Penile Cancer

Prostate Cancer

Cancer of the prostate gland. Treatment depends on risk stratification, ranging from active surveillance to surgery, radiation, hormone therapy, and PSMA-targeted radiopharmaceuticals.

Rectal Cancer

Retinoblastoma

Rhabdomyosarcoma